Schrag Deborah, Panageas Katherine S, Riedel Elyn, Cramer Laura D, Guillem Jose G, Bach Peter B, Begg Colin B
Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Department of Medicine, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Ann Surg. 2002 Nov;236(5):583-92. doi: 10.1097/00000658-200211000-00008.
To compare surgeon and hospital procedure volume as predictors of outcomes for patients with rectal cancer.
Although a "volume-outcome" relationship exists for several major cancer operations, the impact of procedure volume on outcomes following rectal cancer surgery remains uncertain, and it has not been determined whether hospital or surgeon volume is a more important predictor of outcomes.
A retrospective population-based cohort study utilizing the Surveillance, Epidemiology and End Results (SEER)-Medicare linked database identified 2,815 rectal cancer patients aged 65 and older who had surgery for a primary tumor diagnosed in 1992-1996 in a SEER area. Hospital- and surgeon-specific procedure volume was ascertained based on the number of claims submitted over the 5-year study period. Outcome measures were mortality at 30 days and 2 years, overall survival, and the rate of abdominoperineal resections. Age, sex, race, comorbid illness, cancer stage, and socioeconomic status were used to adjust for differences in case mix.
Neither hospital- nor surgeon-specific procedure volume was significantly associated with 30-day postoperative mortality or rates of rectal sphincter-sparing operations. Although an association between hospital volume and mortality at 2 years was evident, this finding was no longer significant once surgeon-specific volume was controlled for. In contrast, surgeon-specific volume was associated with 2-year mortality and remained an important predictor even after adjustment for hospital volume. Surgeon volume was also better than hospital procedure volume at predicting long-term survival.
Surgeon-specific experience as measured by procedure volume can have a significant impact on survival for patients with rectal cancer.
比较外科医生和医院的手术量,以此作为直肠癌患者预后的预测指标。
尽管几种主要癌症手术存在“手术量-预后”关系,但手术量对直肠癌手术后预后的影响仍不确定,而且尚未确定医院手术量还是外科医生手术量是更重要的预后预测指标。
一项基于人群的回顾性队列研究,利用监测、流行病学与最终结果(SEER)-医疗保险链接数据库,确定了2815名65岁及以上的直肠癌患者,他们于1992 - 1996年在SEER地区因原发性肿瘤接受手术。根据5年研究期间提交的索赔数量确定医院和外科医生的特定手术量。结局指标为30天和2年死亡率、总生存率以及腹会阴联合切除术的发生率。采用年龄、性别、种族、合并症、癌症分期和社会经济状况来调整病例组合的差异。
医院特定手术量和外科医生特定手术量均与术后30天死亡率或保留直肠括约肌手术的发生率无显著关联。尽管医院手术量与2年死亡率之间存在明显关联,但在控制了外科医生特定手术量后,这一发现不再显著。相比之下,外科医生特定手术量与2年死亡率相关,即使在调整了医院手术量后仍是一个重要的预测指标。在预测长期生存方面,外科医生手术量也优于医院手术量。
以手术量衡量的外科医生特定经验对直肠癌患者的生存有显著影响。